Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Losses? The stock has moved from
.03 to .21 in less than a year with a small pullback to .18
That's a GAIN and a BIG GAIN not a loss!
Are you going to sh** on Nvidia, for not setting a new 52 week high everyday? Didn't think so..
Next earnings release and conference call ONLY 6 weeks away!
Clown crew out in force trying their best to scare people.
Don't listen to them!
This is a gem & solid buy here. Look at the chart. It's in an UPTREND!
Elite actually sold 5 drugs in total to Nostrum in a short span for 300k each (1.5m total).
One can debate why they are buying these 3 back and not the other 2.
Imo, each of these three are more valuable than the other 2. Never made sense to me that they all had an identical price tag of 300K.
I could not find a buyback clause in the original 8Ks either. I think what is telling is that Nostrum was, "obligated" to make this deal, per the recent 8k.
I expect Nasrat will give an explanation on the call.
I'm mostly interested in hearing if elite will be launching these products and when
So Elite sold them to Nostrum for 300k each and bought them back for 300k each? I'm happy about this. What inflation?
Don't be so hard on yourself
Consider yourself lucky!
"NO other stock like this I can find"
Nasrat, and board of directors, I implore you, get a move on it! Stand by your word. Do your duty. EVERYTHING in your power should be done to create value for ALL the shareholders of Elite.
-file for Nasdaq listing
-bring 100% of the Adderall ANDAs over to elite
-partner or merge with an R&D company
-OR sell the company to the highest bidder ASAP. That is an option!
We have waited patiently and believed the story we have been given by Elite. Time to deliver.
~Very, very, very long time shareholder
The potential of this product for elite is far from being maximized. Elite needs to push to ramp the distribution of ER.
*Side note..elites biggest concern is finding a way to add an NDA to the pipeline again. Get something going or partner with someone who has.
Nasrat, please be working on this. Any % of something, is more than 100% of nothing.
Is anyone familiar with the new MM here, "JANE"
My understanding is they are a proprietary trading firm (trade for the firms gain). I don't believe they provide order flow for retail clients, but I may be wrong.
I've read they work with institutions.
I see this as a POSITIVE they are here and showing up on the bid.
Not diluting they say...
It seems certain there are products in development that have not yet been disclosed. They are moving on something(s).
An announcement on new product development or trials to continue development on an existing product could really get the stock moving in the northern direction.
Be on the lookout for a surprise upside catalyst the second half of the year
No.
840,404,367shares outstanding today + 158,017,312 for the conversion of Nasrats's preferred shares = 998,412,678 OS
I used 1,100,000,000 OS
The .127 per share is conservative
If/when elite turns 2mil earnings/profit a quarter (they are getting close) the share price is fairly valued in the .20s
Again .127 a share is MINIMUM fair value TODAY
Minimum fair value today is .127 a share. The stock is undervalued currently. If you add in products in development and expected revenue growth the true fair value is substantially higher.
Here's the math..
Price to sales and price to Enterprise value for the drug pharmaceutical industry is 4.97 and 5.44.
28,000,000sales(7milx4) x 5 =
140,000,000
140,000,000/
1,100,000,000shares=
.127 a share fair value without any growth whatsoever and the conversion of Nasrats shares priced in
This is based on sales/revenue..not earnings
I need this explained:
"On April 3, 2020, Elite and SunGen mutually agreed to discontinue any further joint product development activities under the SunGen Agreement.
In May 2020, SunGen, under an asset purchase agreement, assigned its rights and obligations under the SunGen Agreement for Amphetamine IR and Amphetamine ER to Mikah Pharmaceuticals. The ANDAs for Amphetamine IR and Amphetamine ER are now registered under Elite’s name. Mikah will now be Elite’s partner with respect to Amphetamine IR and ER and will assume all the rights and obligations for these products from SunGen."
Shouldn't these news items require a PR?
Why did this happen, how did it happen, what does is mean for Elite?
I did send in a question for the CC today regarding the above. 30min late per elites deadline, but has to be included imo!
I've listened to several of elites conference calls over the years and this is the first I can recall Nasrat speaking about..
1) Mergers & Acquisitions as a way to grow the company
2) Conference calls most likely being run differently at some point in the future
Foreshadowing?? He brought these up without being prompted or asked directly.
To each there own, but IMO now is not the time to sell. IT'S A TIME TO BUY! Near term approvals, filings, and launches along with increasing revenues are all in motion!
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations, not some one time payment. BIG NEWS!
Elite turned a profit this quarter and that is without counting the 600k from the sale of the two andas. You have to add that in on top of the 600k profit
I do believe we are cash flow positive! The net loss was derivative in nature due to the rising share price.
I'll throw my hat in the ring. Notch 5.6 for me please.
Anyone think VERT is on the bid and ask for Lincoln Park?
Oh, so who was bidding the stock up last week? The "many" waiting?
Stocks that show improvements fundamentally & technically don't fall long term..they rise.
Time for next leg up here. Get in..
They have been selling at the ask and buying back immediately to cover on the bid all morning
ASCM MM is playing the run up & trying to short here today. Knock them off the ask & we move up
Take a look at the preliminary financials again. Notice the huge improvement in margins and net losses in the last 3 months compared to the year. Interesting to say the least
Upcoming catalysts? Looks like financials coming out tomorrow?
The gap may fill, but it is it not a sure thing as you purpose. Breakaway gaps happen all the time. Gaps created by good news and coupled with substantial increase in volume have a much greater chance holding.
Elite stock is undeniably worth more today than it was yesterday and should continue to climb in anticipation of another near term fda approval, fda filing, and launch of Percocet.
WeeZuhl, I appreciate the time you have taken to share your insites and inject some humor into this board. Your posts are thoughtful and knowledgeable, ty. I too have been a shareholder since the lodrane days. The wait has been frustrating, but I know that elite has something worth waiting for. I am well aware of their pipeline and filings. I can hear in Nasrats voice he is working hard and he believes his efforts will be rewarded.
Us longs must remember that a bit of good news can and will turn this company/stock around in a hurry. A lot is being worked on at elite per the last cc. Nasrat has had the patience to wait, and so do I. Here's to hearing some good news out of elite closing out 2017 and throughout 2018.
I've been meaning/wanting to reach out to Diane. I'd like to hear about the companies strategy going forward. A cc with a Q&A would be nice right about now.
Anyone talk to her since the news?
Hey Weez. Love your posts, keep em coming. Lol, on the camargo line!
My 2 cents on the news. I may be stating the obvious here. At first I was disappointed, but after thinking this through..it is good news. Yes a small delay, but reasoning tells me the results of study must be good (sequestox performed well). Why else carry on? At this point Nasrat has information from the study and simply needs the qualifying # of participants to publish the good results.
If the results in weren't good, elite wouldn't be moving forward with the existing study.
Nasrat already knows that the reformulation is bioequivalent
Diane is out..remember? We got the B team on prs. She'd have saved this gem for the morning for sure!
Was just thinking that myself.
Trades going thru @ .215...hurry and sell @ .20, lol!
Ama, you are 100% correct on this. The fda did either "change their mind on the tmax" or intentionally sabotage the process. I've done my research and believe this wholeheartedly. People who doubt should search "fda guidance for b/e".
Nasrat was following the guidance and instructions given to him directly by the fda. There were meetings between elite and the fda before all this even started. Nasrat had all the information he needed to get sequestox approved in a timely manner.
Fda pulled a "switcherooo"!
As in 7 million shares?
What are you talking about? Rallies don't take place all in one day. I'll take 5% a day in any of my investments.
Nasrat. Please give us long term shareholders some good news today. I've been a believer, but would like some transparency. Thx!
Fill the gap
This is great buy here folks